A panel advisory for the Centers for Disease Control and Prevention said Thursday that they prefer Pfizer and Moderna to receive their vaccines. Johnson & Johnson‘s shot for adults 18 and over, after finding dozens of people developed a rare blood clot condition following J&J vaccination, all of whom were hospitalized and nine of whom died.

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. Rochelle Walensky, Director of CDC, still needs to comment on the recommendation.

The CDC reported 54 cases in which people developed blood clots. They also showed low levels of blood platelets. This new condition is called thrombosis and thrombocytopenia, and it mostly affects women younger than 50. Nine people succumbed to their injuries, while 36 received intensive medical care.

According to Dr. Keipp, chairman of the CDC’s vaccine and safety subgroups, “The TTS cases reporting rates after Janssen vaccines are higher than previously estimated in men as well women in a larger age range,” Talbot told the advisory board.

Two of the victims who died in their deaths were both women, and seven were all females with an average age of 45. Many of the patients who died were suffering from underlying conditions like diabetes, obesity and hypertension. According to the CDC., 0.57 people died from each million doses.

The advisory panel was told by Dr. Isaac See from the CDC’s vaccine safety group, “We have been struck upon reviewing these cases by the rapid patient status deteriorates, and results in death.”

According to the CDC, patients often developed symptoms nine days following vaccination. They were admitted to hospital five days later. There were 37 patients with TTS, the majority being women. The median age for all of them was 44. Seventeen men developed TTS.

Johnson & Johnson’s Penny Heaton, global therapeutics area head for vaccines, defended the company’s shot during the meeting, saying it “is saving lives here in the USA and on every continent around the globe.”

Heaton explained that it is simple to store and transport. Our vaccine may be considered the most effective and often the best option for many people in low- and middle-income countries. This is because of its durability and protection.

Heaton said J&J recognizes the incidents of TTS associated with the vaccine and that the condition can be fatal, though the cases are rare. She said patient safety and well being remains J&J’s top priority, and the company has several studies underway to identify risk factors associated with the development of TTS.

The Food and Drug Administration and CDC were both established in April. briefly halted the use Johnson & Johnson’s single-shot vaccine, after six adult women developed blood clots and low blood platelet levels at the same time.

The FDA and the CDC merged the FDA and CDC a week later. lifted the pause on J&J shots after the independent advisory panel said the benefits of the shots outweighed the risks. At the time, the panel did not suggest that shots be restricted by gender or age. The FDA should add a warning label to women under 50 years of age.

The FDA has told health-care providers that they shouldn’t administer a J&J booster to people who have a history of developing TTS after the first shot. The FDA also said the J&J shot should not be administered to people who received AstraZeneca’s vaccine, though AstraZeneca is not authorized for use in the U.S.

CDC experts on Thursday said no TTS cases have been identified in people who have received J&J booster doses, though the number of boosters is relatively small.

The FDA stated in a factsheet to health-care professionals that “current evidence supports a causal relation between TTS, the Janssen COVID-19 vaccine,”

October saw the FDA and CDC merge. authorized J&J boosters for all adults at least two months after receiving their initial J&J shot. More than 800,00 people have received J&J boosters, according to CDC data. People who received their primary vaccination with the J&J shot can also get boosted with the Pfizer or Moderna vaccines.

This is important breaking news. Stay tuned for new updates.